DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
First-quarter 2024 revenues totaled $14.9 billion, a decrease of $3.6 billion, or 20%, compared to the prior-year quarter
Sales reflect continued strong growth in oncology and vaccines
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers
NM5072 is an anti-Properdin antibody that selectively blocks the alternative pathway while maintaining the integrity of the classical pathway required for fending off infections
Submission based on results from pivotal phase III trial showing all primary endpoints met
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Subscribe To Our Newsletter & Stay Updated
